"False"
Hoppa direkt till innehållet
umu.se
För studenter
Bibliotek
För medarbetare
Logga in
Student
Alla studenter måste byta lösenord efter 7 maj.
Redigera
Redigera innehåll på umu.se
English site
Sök
Meny
X stäng menyn
Meny
Sök
Sök inom:
Sök inom:
Allt
Utbildning
Forskning
Personal
Studentwebb
Nyheter
Andra söktjänster
Hitta kurser och program
Sök kursplan
Sök välkomstbrev
Bibliotekets söktjänst
Sök i regelverket
Huvudmenyn dold.
Logga in
Student
Alla studenter måste byta lösenord efter 7 maj.
Redigera
Redigera innehåll på umu.se
English
Michael Bergqvist
Kontakt
E-post
michael.bergqvist@akademiska.se
Telefon
090-786 50 77
Verksam vid
Anknytning
Adjungerad professor vid
Institutionen för diagnostik och intervention
Enhet: Onkologi
Plats
Sjukhuset i Gävle
Umeå universitet, 901 85 Umeå
Publikationer
Publikationer
2024
Regional perspectives on complementary and alternative medicine: results of a regional survey
Complementary Medicine Research
Källman, Mikael; Bergström, Stefan; Holgersson, Georg; et al.
2023
Use of CAM among cancer patients: results of a regional survey in Sweden
BMC Complementary Medicine and Therapies
, BioMed Central (BMC) 2023, Vol. 23, (1)
Källman, Mikael; Bergström, Stefan; Carlsson, Tobias; et al.
2022
Reply to Assoc. Prof. Kocak
Acta Oncologica
, Taylor & Francis Group 2022, Vol. 61, (3) : 320-320
Willén, Linda; Berglund, Anders; Bergström, Stefan; et al.
2022
Are older patients with non-small cell lung cancer receiving optimal care? A population-based study
Acta Oncologica
, Taylor & Francis 2022, Vol. 61, (3) : 309-317
Willén, Linda; Berglund, Anders; Bergström, Stefan; et al.
2022
Patterns of care and outcomes in immigrants with non-small cell lung cancer: a population-based study (Sweden)
PLOS ONE
, Public Library of Science 2022, Vol. 17, (12)
Willén, Linda; Berglund, Anders; Bergström, Stefan; et al.
2021
Radiotherapy as elective treatment of the node-negative neck in oral squamous cell cancer
Anticancer Research
, Vol. 41, (7) : 3489-3498
Lundin, Erik; Reizenstein, Johan; Landstrom, Fredrik; et al.
2020
Real world utilization of EGFR TKIs and prognostic factors for survival in NSCLC during 2010-2016 in Sweden: A nationwide observational study
International Journal of Cancer
, John Wiley & Sons 2020, Vol. 146, (9) : 2510-2517
Bergqvist, Michael; Christensen, Helene N.; Wiklund, Fredrik; et al.
2019
No Evidence for Increased Brain Tumour Incidence in the Swedish National Cancer Register Between Years 1980-2012
Anticancer Research
, International Institute of Anticancer Research 2019, Vol. 39, (2) : 791-796
Nilsson, Jonas; Järås, Jacob; Henriksson, Roger; et al.
2019
Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based study
Lung Cancer
, Elsevier 2019, Vol. 131 : 40-46
Willén, Linda; Berglund, Anders; Bergström, Stefan; et al.
2019
Små och minskande skillnader i lungcancervården
Läkartidningen
Willén, Linda; Isaksson, Johan; Bergström, Stefan; et al.
2018
Characteristics and Long-Term OS of Non-Small Cell Lung Cancer Patients Receiving EGFR Tyrosine Kinase Inhibitor Treatment
Journal of Thoracic Oncology
, Elsevier 2018, Vol. 13, (10) : S419-S419
Bergqvist, Michael; Christensen, H. Nordahl; Wiklund, F.; et al.
2018
EGFR tyrosine kinase inhibitors in non-small cell lung cancer: Nationwide register-based cohort study in Sweden
Annals of Oncology
, Oxford University Press 2018, Vol. 29 : 526-526
Bergström, S.; Christensen, H. Nordahl; Wiklund, F.; et al.
2018
CD93 promotes beta(1) integrin activation and fibronectin fibrillogenesis during tumor angiogenesis
Journal of Clinical Investigation
, AMER SOC CLINICAL INVESTIGATION INC 2018, Vol. 128, (8) : 3280-3297
Lugano, Roberta; Vemuri, Kalyani; Yu, Di; et al.
2018
The role of income in brain tumor patients: a descriptive register-based study
Medical Oncology
, Humana Press 2018, Vol. 35, (4)
Nilsson, Jonas; Holgersson, Georg; Järås, Jacob; et al.
2017
Phase II randomized study of the IGF-1R pathway modulator AXL1717 compared to docetaxel in patients with previously treated, locally advanced or metastatic non-small cell lung cancer
Acta Oncologica
, Vol. 56, (3) : 441-447
Bergqvist, Michael; Holgersson, Georg; Bondarenko, Igor; et al.
2017
Affinity Proteomics Exploration of Melanoma Identifies Proteins in Serum with Associations to T-Stage and Recurrence
Translational Oncology
, Vol. 10, (3) : 385-395
Bystrom, Sanna; Fredolini, Claudia; Edqvist, Per-Henrik; et al.
2017
The prognostic value of pre-treatment leukocytosis in patients with previously treated, stage IIIB/IV non-small cell lung cancer treated with the IGF-1R pathway modulator AXL1717 or docetaxel: a retrospective analysis of a phase II trial
Asian Pacific Journal of Cancer Prevention
, Vol. 18, (6) : 1555-1560
Holgersson, Georg; Bergqvist, Michael; Nilsson, R. Jonas A.; et al.
2017
The prognostic value of pre-treatment thrombocytosis in two cohorts of patients with non-small cell lung cancer treated with curatively intended chemoradiotherapy
Neoplasma (Bratislava)
, Bratislava: AEPress 2017, Vol. 64, (6) : 909-915
Holgersson, Georg; Bergström, Stefan; Hallqvist, Anders; et al.
2017
End-of-life care: Where do cancer patients want to die? A systematic review
Asia-Pacific Journal of Clinical Oncology
, John Wiley & Sons 2017, Vol. 13, (6) : 356-364
Nilsson, Jonas; Blomberg, Carl; Holgersson, Georg; et al.
2017
Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression
Oncotarget
, Vol. 8, (15) : 24815-24827
Roy, Ananya; Attarha, Sanaz; Weishaupt, Holger; et al.
2016
A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial
Acta Oncologica
, Vol. 55, (2) : 140-148
Ekman, Simon; Harmenberg, Johan; Frödin, Jan-Erik; et al.
2015
Brain tumors in Sweden: Data from a population-based registry 1999-2012
Acta Oncologica
, Vol. 54, (3) : 377-384
Asklund, Thomas; Malmström, Annika; Bergqvist, Michael; et al.
2015
A phase I pilot study of the insulin-like growth factor 1 receptor pathway modulator AXL1717 in combination with gemcitabine HCl and carboplatin in previously untreated, locally advanced, or metastatic non-small cell lung cancer
Medical Oncology
, Vol. 32, (4)
Holgersson, Georg; Bergström, Stefan; Harmenberg, Johan; et al.
2015
Effect of Increased Radiotoxicity on Survival of Patients with Non-small Cell Lung Cancer Treated with Curatively Intended Radiotherapy
Anticancer Research
, Vol. 35, (10) : 5491-5497
Holgersson, Georg; Bergström, Stefan; Liv, Per; et al.
2015
FGF2 as a potential prognostic biomarker for proneural glioma patients
Acta Oncologica
, Informa Healthcare 2015, Vol. 54, (3) : 385-394
Sooman, Linda; Freyhult, Eva; Jaiswal, Archita; et al.
2014
Human Cytomegalovirus Tegument Protein pp65 Is Detected in All Intra- and Extra-Axial Brain Tumours Independent of the Tumour Type or Grade
PLOS ONE
, Vol. 9, (9) : e108861-
Libard, Sylwia; Popova, Svetlana N.; Amini, Rose-Marie; et al.
2013
The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancer
Medical Oncology
, Humana Press 2013, Vol. 30, (1)
Holgersson, Georg; Bergqvist, Michael; Nyman, Jan; et al.
Depression, anxiety, intoxication and suicide following a diagnosis of non-small cell lung cancer: A population-based study (Sweden)
Willén, Linda; Berglund, Anders; Bergström, Stefan; et al.
Visa publikationer i DiVA
+ Visa mer
- Visa mindre